文献速递衰弱、肌少症与跌倒

肌母细胞线粒体功能障碍:TSPO依赖性肌少症机制

Mitochondrial Dysfunction in Myoblasts: A TSPO-Dependent Mechanism of Sarcopenia.
PubMed 文献 · J Gerontol A Biol Sci Med Sci · 2026-06-02

本研究在C2C12肌母细胞和老年小鼠中揭示线粒体转运蛋白TSPO是肌生成的负调控因子,在衰老和肌少症肌肉中上调。TSPO过表达破坏线粒体稳态并损害增殖分化,敲低则相反;机制上TSPO抑制Wnt/β-catenin通路且部分由ROS积累介导。AAV9介导的老年小鼠TSPO敲低恢复线粒体完整性并改善肌肉质量、力量和运动表现。

要点

  • TSPO在衰老和肌少症肌肉中上调,是肌生成负调控因子。
  • TSPO通过抑制Wnt/β-catenin通路(部分由ROS介导)损害肌生成。
  • AAV9介导TSPO敲低改善老年小鼠肌肉质量、力量和运动表现。

核心结论

  • TSPO-Wnt/β-catenin轴将线粒体功能障碍与衰老中肌肉再生受损联系起来,靶向TSPO可能通过增强线粒体生物能量和重新激活促肌生成信号双效对抗肌少症。

研究设计与样本

  • 在C2C12肌母细胞中采用功能获得和功能缺失方法研究TSPO对肌生成的影响。
  • 在老年小鼠中采用AAV9介导的TSPO敲低进行体内验证。

主要发现

  • TSPO过表达破坏线粒体稳态并损害增殖和分化,TSPO敲低产生相反效应。
  • TSPO抑制Wnt/β-catenin通路,该效应部分由ROS积累介导。
  • 老年小鼠体内AAV9介导的TSPO敲低恢复线粒体完整性并显著改善肌肉质量、力量和运动表现。

临床怎么用

  • 靶向TSPO可能成为同时增强线粒体生物能量和重新激活促肌生成信号的双效治疗策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Sarcopenia, the age-related loss of muscle mass and function, poses a significant health burden in aging societies. Although mitochondrial dysfunction is a recognized driver, the upstream molecular regulators remain poorly defined. Here, we identify the mitochondrial translocator protein (TSPO) as a novel negative regulator of myogenesis that is consistently upregulated in aged and sarcopenic muscle. Using gain- and loss-of-function approaches in C2C12 myoblasts, we show that TSPO overexpression disrupts mitochondrial homeostasis, impairs proliferation and differentiation, while TSPO knockdown produces opposite effects-establishing TSPO as a critical modulator of myogenic capacity. Mechanistically, TSPO suppresses the Wnt/β-catenin pathway, and this effect is partially mediated by ROS accumulation. Importantly, in vivo AAV9-mediated TSPO knockdown in aged mice not only restores mitochondrial integrity but also significantly improves muscle mass, strength, and exercise performance. Collectively, our findings uncover a TSPO-Wnt/β-catenin axis that links mitochondrial dysfunction to impaired muscle regeneration in aging. Targeting TSPO may offer a dual-action therapeutic strategy to combat sarcopenia by simultaneously enhancing mitochondrial bioenergetics and reactivating pro-myogenic signaling.

来源:J Gerontol A Biol Sci Med Sci,查看原文。版权归原作者所有。

引用

  1. Zhang P, Zheng H, Lin Z, et al. Mitochondrial Dysfunction in Myoblasts: A TSPO-Dependent Mechanism of Sarcopenia. J Gerontol A Biol Sci Med Sci. 2026. PMID: 42226012. doi:10.1093/gerona/glag145

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。